Investors / Singapore / Vertex Ventures HC
Vertex Ventures HC
Venture capital · Singapore, Singapore · Asia Pacific
Vertex Ventures HC is a venture capital fund that is part of the Vertex global network of venture capital funds, which includes affiliates in China, Israel, Japan, Southeast Asia and India, and the US. It has built a portfolio of healthcare companies developing transformative therapies and medical technologies and focuses on supporting its portfolio through key growth and value-creation milestones.
Invests inHealthcare & Biotech
In its own wordshealthcarebiotechmedtechtherapeuticslife sciences
Your fit with Vertex Ventures HC
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsVertex Ventures HC lists 6 checked portfolio companies on its own site and is named in 1 funding round. Its most frequent entry is Series B, 100% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 100% of its companies are based in United States. It invests most often alongside ARCH Venture Partners, Casdin Capital and Nextech Invest.
Counts come from funding rounds that name Vertex Ventures HC, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundVertex Ventures HC does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 0% |
| Series B | 100% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 1 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 8th | 6 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 19th | 1 country |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| ARCH Venture Partners | 3 |
| Casdin Capital | 2 |
| Nextech Invest | 2 |
| RA Capital | 2 |
| T1D Fund | 2 |
| Vivo Capital | 2 |
| 8VC | 1 |
| ARK Venture Fund | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers6100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with ARCH Venture Partners
Compare Vertex Ventures HC head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Vertex Ventures HC| Date | Company | Stage |
|---|---|---|
| 10 Jun 2026 | Series B |
Round details for Vertex Ventures HC
Amounts, full round histories and every co-investor in Vertex Ventures HC's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
6 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Boundless Bio develops therapies for patients with intractable oncogene amplified cancers. | Healthcare & Biotech | Portfolio page | ||
| Matchpoint Therapeutics is discovering precision small molecule medicines to transform the treatment of immune diseases. | Healthcare & Biotech | Portfolio page | ||
| Neuspera Medical develops implantable medical devices for treating urinary urge incontinence and overactive bladder | Healthcare & Biotech | Portfolio page | ||
| Palleon Pharmaceuticals pioneers next-generation autoimmune and cancer medicines through glycobiology | Healthcare & Biotech | Portfolio page | ||
| The company engineers a patient's own regulatory T cells to correct the immune dysfunction driving autoimmune disease. | Healthcare & Biotech | Portfolio page | ||
| SonoThera is developing a proprietary, nonviral, non-invasive approach for genetic medicine using ultrasound-mediated delivery | Healthcare & Biotech | Jun 2026Series B | Funding round |
About this data
site last read 5 Nov 2026- Site
- vertexventureshc.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 10 Jun 2026
- Companies checked
- 6
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Vertex Ventures HC's profile as data
Pull Vertex Ventures HC's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/vertexventureshc.com
# also
GET /v1/firms/vertexventureshc.com/portfolio
GET /v1/firms/vertexventureshc.com/coinvestors
GET /v1/firms/vertexventureshc.com/news